Search
for
Sort by
Research 31–60 of 43
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Metabolic syndrome — a new definition and management guidelines
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Role of ACE2 polymorphism in COVID-19: impact of age
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Prevalence of Systemic Hypertension and Control of Systolic Blood Pressure in a Cohort of 14 Dogs with Adrenal-Dependent Hypercortisolism during the First Year of Trilostane Treatment or after Adrenalectomy
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Analysis of post-COVID symptoms and predisposing factors for chronic post-COVID syndrome
- Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses
- Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss
- Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
- Repurposing of approved cardiovascular drugs
- COVID-19 and Sex Differences
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- New developments in occupational dermatology
- Transgender and Migraine
- Scaled Quantum Chemical Studies of the Molecular Structure and Vibrational Spectra of Minoxidil
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Menopause
- Diuretics
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine